139 related articles for article (PubMed ID: 38222349)
21. Using data science to improve outcomes for persons with opioid use disorder.
Hayes CJ; Cucciare MA; Martin BC; Hudson TJ; Bush K; Lo-Ciganic W; Yu H; Charron E; Gordon AJ
Subst Abus; 2022; 43(1):956-963. PubMed ID: 35420927
[TBL] [Abstract][Full Text] [Related]
22. Publicly available machine learning models for identifying opioid misuse from the clinical notes of hospitalized patients.
Sharma B; Dligach D; Swope K; Salisbury-Afshar E; Karnik NS; Joyce C; Afshar M
BMC Med Inform Decis Mak; 2020 Apr; 20(1):79. PubMed ID: 32349766
[TBL] [Abstract][Full Text] [Related]
23. Assessing perceptions about medications for opioid use disorder and Naloxone on Twitter.
Tofighi B; El Shahawy O; Segoshi A; Moreno KP; Badiei B; Sarker A; Krawczyk N
J Addict Dis; 2021; 39(1):37-45. PubMed ID: 32835641
[No Abstract] [Full Text] [Related]
24. Variation in Initiation, Engagement, and Retention on Medications for Opioid Use Disorder Based on Health Insurance Plan Design.
Morgan JR; Quinn EK; Chaisson CE; Ciemins E; Stempniewicz N; White LF; Linas BP; Walley AY; LaRochelle MR
Med Care; 2022 Mar; 60(3):256-263. PubMed ID: 35026792
[TBL] [Abstract][Full Text] [Related]
25. Predictors of availability of long-acting medication for opioid use disorder.
Shover CL; Humphreys K
Drug Alcohol Depend; 2019 Nov; 204():107586. PubMed ID: 31593871
[TBL] [Abstract][Full Text] [Related]
26. Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic.
Jones CM; Shoff C; Hodges K; Blanco C; Losby JL; Ling SM; Compton WM
JAMA Psychiatry; 2022 Oct; 79(10):981-992. PubMed ID: 36044198
[TBL] [Abstract][Full Text] [Related]
27. Identifying key risk factors for premature discontinuation of opioid use disorder treatment in the United States: A predictive modeling study.
Stafford C; Marrero WJ; Naumann RB; Lich KH; Wakeman S; Jalali MS
Drug Alcohol Depend; 2022 Aug; 237():109507. PubMed ID: 35660221
[TBL] [Abstract][Full Text] [Related]
28. Impact of a pharmacist-led substance use disorder transitions of care clinic on postdischarge medication treatment retention.
Smith A; Hansen J; Colvard M
J Subst Abuse Treat; 2021 Nov; 130():108440. PubMed ID: 34118708
[TBL] [Abstract][Full Text] [Related]
29. Naturalistic follow-up after a trial of medications for opioid use disorder: Medication status, opioid use, and relapse.
Greiner MG; Shulman M; Choo TH; Scodes J; Pavlicova M; Campbell ANC; Novo P; Fishman M; Lee JD; Rotrosen J; Nunes EV
J Subst Abuse Treat; 2021 Dec; 131():108447. PubMed ID: 34098301
[TBL] [Abstract][Full Text] [Related]
30. A machine learning based two-stage clinical decision support system for predicting patients' discontinuation from opioid use disorder treatment: retrospective observational study.
Hasan MM; Young GJ; Shi J; Mohite P; Young LD; Weiner SG; Noor-E-Alam M
BMC Med Inform Decis Mak; 2021 Nov; 21(1):331. PubMed ID: 34836524
[TBL] [Abstract][Full Text] [Related]
31. Outcomes associated with the use of medications for opioid use disorder during pregnancy.
Krans EE; Kim JY; Chen Q; Rothenberger SD; James AE; Kelley D; Jarlenski MP
Addiction; 2021 Dec; 116(12):3504-3514. PubMed ID: 34033170
[TBL] [Abstract][Full Text] [Related]
32. Criminal problem-solving and civil dependency court policies regarding medications for opioid use disorder.
Andraka-Christou B; Clark MH; Atkins DN; Del Pozo B
Subst Abus; 2022; 43(1):425-432. PubMed ID: 34236297
[No Abstract] [Full Text] [Related]
33. Effects of Bundling Medication for Opioid Use Disorder With an mHealth Intervention Targeting Addiction: A Randomized Clinical Trial.
Gustafson DH; Landucci G; Vjorn OJ; Gicquelais RE; Goldberg SB; Johnston DC; Curtin JJ; Bailey GL; Shah DV; Pe-Romashko K; Gustafson DH
Am J Psychiatry; 2024 Feb; 181(2):115-124. PubMed ID: 37789744
[TBL] [Abstract][Full Text] [Related]
34. Long-term treatment retention in West Virginia's comprehensive opioid addiction treatment (COAT) program.
Lander LR; Zheng W; Hustead JD; Mahoney JJ; Berry JH; Marshalek P; Winstanley EL
J Neurol Sci; 2020 Apr; 411():116712. PubMed ID: 32058182
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness of medication for opioid use disorders in transition-age youth: A systematic review.
Becker SJ; Scott K; Helseth SA; Danko KJ; Balk EM; Saldanha IJ; Adam GP; Steele DW
J Subst Abuse Treat; 2022 Jan; 132():108494. PubMed ID: 34098208
[TBL] [Abstract][Full Text] [Related]
36. Low barrier medication for opioid use disorder at a federally qualified health center: a retrospective cohort study.
Carter J; Li Z; Chen H; Greiner M; Bush C; Bhattacharya D; Poley S; Sachdeva N; Crowder JC; Feigal J
Addict Sci Clin Pract; 2022 Nov; 17(1):60. PubMed ID: 36335381
[TBL] [Abstract][Full Text] [Related]
37. Psychosocial and behavioral therapy in conjunction with medication for opioid use disorder: Patterns, predictors, and association with buprenorphine treatment outcomes.
Samples H; Williams AR; Crystal S; Olfson M
J Subst Abuse Treat; 2022 Aug; 139():108774. PubMed ID: 35337716
[TBL] [Abstract][Full Text] [Related]
38. Duration of medication treatment for opioid-use disorder and risk of overdose among Medicaid enrollees in 11 states: a retrospective cohort study.
Burns M; Tang L; Chang CH; Kim JY; Ahrens K; Allen L; Cunningham P; Gordon AJ; Jarlenski MP; Lanier P; Mauk R; McDuffie MJ; Mohamoud S; Talbert J; Zivin K; Donohue J
Addiction; 2022 Dec; 117(12):3079-3088. PubMed ID: 35652681
[TBL] [Abstract][Full Text] [Related]
39. "Sick and tired of being sick and tired": Exploring initiation of medications for opioid use disorder among people experiencing homelessness.
Swartz N; Adnan T; Peréa F; Baggett TP; Chatterjee A
J Subst Abuse Treat; 2022 Jul; 138():108752. PubMed ID: 35277306
[TBL] [Abstract][Full Text] [Related]
40. Long-term treatment retention of an emergency department initiated medication for opioid use disorder program.
Reuter QR; Santos AD; McKinnon J; Gothard D; Jouriles N; Seaberg D
Am J Emerg Med; 2022 May; 55():98-102. PubMed ID: 35304308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
